Patient Guide: RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 118 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04597125
Status: ACTIVE_NOT_RECRUITING
Condition: Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Phase: PHASE4

Find a Study Location Near You

This study is available at 118 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Castle Hill, New South Wales
  • Gosford, New South Wales
  • Kingswood, New South Wales
  • • And 115 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily